CYP19A1 and breast carcinoma: It has been reported that the presence of two tightly linked single nucleotide polymorphisms (SNPs), rs6493497 and rs7176005, in the 5′-flanking region of the CYP19A1 exon 1.1 is associated with greater decrease in aromatase activity following anastrozole neoadjuvant treatment in breast cancer (3).